Brain parenchyma sonography detects preclinical parkinsonism

被引:120
作者
Walter, U
Klein, C
Hilker, R
Benecke, R
Pramstaller, PP
Dressler, D
机构
[1] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany
[2] Univ Luebeck, Dept Neurol, Lubeck, Germany
[3] Univ Cologne, Dept Neurol, Cologne, Germany
[4] Reg Gen Hosp, Dept Neurol, Bolzano, Italy
关键词
brain parenchyma sonography; Parkinson's disease; parkin; PARK2; substantia nigra; substantia nigra hyperechogenicity;
D O I
10.1002/mds.20232
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Substantia nigra (SN) hyperechogenicity on brain parenchyma sonography (BPS) is highly characteristic for idiopathic PD. We studied 7 symptomatic and 7 asymptomatic parkin mutation carriers (PMC) from a large kindred with adult-onset parkinsonism. BPS revealed larger SN echogenic sizes in PMC with parkin mutations on both alleles (homozygous, compound-heterozygous), compared to PMC with only one mutated allele (Mann-Whitney U test, P = 0.007). In symptomatic PMC, larger SN echogenic size was correlated with younger age at onset of the disease (Spearman rank correlation, Rho = -0.937, P = 0.002) but not with age, disease duration, or disease severity. BPS demonstrated SN hyperechogenicity, in concordance with abnormal nigrostriatal F-18-dopa positron emission tomography (PET), in all symptomatic and 3 asymptomatic PMC. In 2 asymptomatic PMC, PET and BPS were normal. However, in another 2 asymptomatic PET-normal PMC, SN hyperechogenicity could be detected. Data suggest SN hyperechogenicity as an early marker to detect preclinical parkinsonism. (C) 2004 Movement Disorder Society.
引用
收藏
页码:1445 / 1449
页数:5
相关论文
共 17 条
[1]   DEGENERATION OF SUBSTANTIA-NIGRA IN CHRONIC PARKINSONS-DISEASE VISUALIZED BY TRANSCRANIAL COLOR-CODED REAL-TIME SONOGRAPHY [J].
BECKER, G ;
SEUFERT, J ;
BOGDAHN, U ;
REICHMANN, H ;
REINERS, K .
NEUROLOGY, 1995, 45 (01) :182-184
[2]   Echogenicity of the substantia nigra -: Association with increased iron content and marker for susceptibility to nigrostriatal injury [J].
Berg, D ;
Roggendorf, W ;
Schröder, U ;
Klein, R ;
Tatschner, T ;
Benz, P ;
Tucha, O ;
Preier, M ;
Lange, KW ;
Reiners, K ;
Gerlach, M ;
Becker, G .
ARCHIVES OF NEUROLOGY, 2002, 59 (06) :999-1005
[3]   Echogenicity of the substantia nigra in Parkinsons disease and its relation to clinical findings [J].
Berg, D ;
Siefker, C ;
Becker, G .
JOURNAL OF NEUROLOGY, 2001, 248 (08) :684-689
[4]   Relationship of substantia nigra echogenicity and motor function in elderly subjects [J].
Berg, D ;
Siefker, C ;
Ruprecht-Dörfler, P ;
Becker, G .
NEUROLOGY, 2001, 56 (01) :13-17
[5]   Vulnerability of the nigrostriatal system as detected by transcranial ultrasound [J].
Berg, D ;
Becker, G ;
Zeiler, B ;
Tucha, O ;
Hofmann, E ;
Preier, M ;
Benz, P ;
Jost, W ;
Reiners, K ;
Lange, KW .
NEUROLOGY, 1999, 53 (05) :1026-1031
[6]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[7]   AGING AND PARKINSONS-DISEASE - SUBSTANTIA-NIGRA REGIONAL SELECTIVITY [J].
FEARNLEY, JM ;
LEES, AJ .
BRAIN, 1991, 114 :2283-2301
[8]   Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra [J].
Felletschin, B ;
Bauer, P ;
Walter, U ;
Behnke, S ;
Spiegel, J ;
Csoti, I ;
Sommer, U ;
Zeiler, B ;
Becker, G ;
Riess, O ;
Berg, D .
NEUROSCIENCE LETTERS, 2003, 352 (01) :53-56
[9]   Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease [J].
Foroud, T ;
Uniacke, SK ;
Liu, L ;
Pankratz, N ;
Rudolph, A ;
Halter, C ;
Shults, C ;
Marder, K ;
Conneally, PM ;
Nichols, WC .
NEUROLOGY, 2003, 60 (05) :796-801
[10]   Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations [J].
Hedrich, K ;
Marder, K ;
Harris, J ;
Kann, M ;
Lynch, T ;
Meija-Santana, H ;
Pramstaller, PP ;
Schwinger, E ;
Bressman, SB ;
Fahn, S ;
Klein, C .
NEUROLOGY, 2002, 58 (08) :1239-1246